Julie L. Sutcliffe, Ph.d

This early-stage study tests a new radioactive tracer called 18F-αvβ6-binding-peptide to see if it can safely and effectively locate primary or metastatic cancers in the breast, colon, lungs, and pancreas. About 27 adults with these cancers will receive the tracer and undergo PET…